Please note that this lecture is part of the PED-153 course curriculum.
Kenneth Weg is founder and chairman of Clearview Projects, Inc. Mr. Weg is engaged in partnering and deal transaction services to biopharmaceutical companies and academic institutions.
Mr. Weg has 33 years of experience in the pharmaceutical industry with Merck, Sharp & Dohme and Bristol-Myers Squibb.
In 1997, Mr. Weg was President, Worldwide Medicines Group, Bristol-Myers Squibb Company responsible for all ethical pharmaceuticals and over-the-counter medicines on a global basis. In March 1993, he served as President, Bristol-Myers Squibb Pharmaceutical Group. He was elected to the Board of Directors and named as an Executive Vice President of Bristol-Myers Squibb Company May 1995. In May 1999, Mr. Weg was elected Vice Chairman of the Board. He retired in February 2001.
Mr. Weg serves on the Board of Directors of GenPath Pharmaceuticals, Inc., Millennium Pharmaceuticals, Inc., and as Vice Chairman of the Board at Fox Chase Cancer Center. He is a member of the Dean's Councils at Harvard University John F. Kennedy School of Government.
Mr. Weg earned a B.A. in English Literature from Dartmouth in 1960, an M.B.A. from Columbia in 1962, and an honorary Doctor of Philosophy from the Medical University of Southern Africa in 2000.
